monophosphoryl lipid A-recognizing antibodies have access to their epitopes in bisphosphoryl compounds as well. Because of this unidirectional reactivity with more complex structures, the various specificities cannot be distinguished by using bisphosphoryl lipid A (e.g., Escherichia coli lipid A) as a test antigen. The epitopes recognized by the various monoclonal antibodies all reside in the hydrophilic backbone of lipid A, and there was no indication that fatty acids were part of the epitopes recognized. Nevertheless, the reactivities of compounds in the different test systems are strongly influenced by their acylation patterns; i.e., acyl groups may modulate the exposure of lipid A epitopes.
Lipopolysaccharides (LPSs) (endotoxin) are amphipathic macromolecules present as common constituents in the cell wall of gram-negative bacteria. All LPSs, regardless of their origin, share a general architecture: they contain a lipid component (termed lipid A) and a heteropolysaccharide. The heteropolysaccharide consists of a core oligosaccharide (core region) and, in the case of members of the family Enterobacteriaceae, of the 0-specific chain. Each of the three LPS regions exhibits distinct immunoreactive properties (4) . The numerous pathophysiological effects (8) of endotoxin are caused by the lipid A portion and can be elicited by synthetic lipid A as well (18) . In addition, lipid A is immunogenic and antigenic and lipid A antibodies crossreact with lipid A from various bacterial species (19) . Since lipid A represents the toxic principle of LPS, antibodies to lipid A may offer a tool for neutralizing the harmful effects of endotoxin. In recent studies, we have identified five distinct lipid A antibody specificities in rabbit sera (6, 7) . All specificities were dependent on the presence of phosphate. One of these specificities comprised the 1,4'-bisphosphoryl hexosamine disaccharide of lipid A, two further specificities comprised either the 1-or the 4'-monophosphorylated disaccharide, and two comprised 1-or 4 -phosphoryl monosaccharide partial structures of lipid A. Since these studies were performed with polyclonal rabbit sera, we asked the question whether similar specificities may be obtained with monoclonal antibodies (MAbs) . Since tuents of synthetic monosaccharides are given in Fig. 2 and Table 2 . Compounds LA-11-HP and LA-11-PH represent lipid X and its 4-phosphoryl isomer (28) . The other synthetic monosaccharide lipid A analogs (30) vary with respect to acylation and phosphorylation. Additionally, in some compounds, D-glucosamine (GlcN) is replaced by either D-glucose (Glc), 3-amino-3-deoxy-D-glucose (Glc3N), or 2,3-diamino-2,3-dideoxy-D-glucose (GlcN3N). The latter glycosyl residue is present in the backbone of the lipid A of a variety of phototrophic and nonphototrophic bacteria (33, 35, 36) .
Liposome membrane-embedded antigens. The preparation of antigens embedded in liposome membranes has been described previously (6) . All lipids were obtained from Sigma Chemical Co. (Munich, Germany). -22-PH C14-O-C14 C14-OH C14-O-C14 C14-OH   P H   LA-20-PP C14-O-C16 C14-OH C14-OH   C14-OH  P P   LA-20-PH C14-O-C16 C14-OH C14-OH   C14-OH  P H  LA-21-PP C14-OH   C14-OH C14-O-C16 C14-OH   P P  LA-21-PH C14-OH   C14-OH C14-O-C16 C14-OH   P H  LA-14-PP C14-OH  C14-OH C14-OH  C14-OH  P P   LA-14-HP C14-OH  C14-OH C14-OH  C14-OH  H P  LA-14-PH C14-OH  C14-OH C14-OH  C14-OH   P H   LA-14-HH C14-OH  C14-OH C14-OH  C14- Per mouse, 20 ,ug of immunogen was injected on days 0 and 7, 60 p.g was injected on day 14, and 120 ,ug was injected on day 21; two booster injections were then administered on days 70 and 132 (50 ,ug each). Ten days after each injection, blood samples were tested with the passive immunohemolysis system (see below). Only after the fourth injection did 4 of 10 mice respond to lipA-HCI-coated bacteria with a low titer. Similarly, mice immunized with LA-15-HP liposomes responded only after the last two injections (three of four mice), and the titers were even lower than those of lipA-HCI-immunized mice. In contrast, all 10 control mice immunized with lipA-Ac-coated bacteria already had significant titers to lipA-Ac after the first booster. Obviously, the complete structure of lipid A is a better immunogen for mice than monophosphoryl derivatives. Four days after the last injection, spleen cells from one mouse of each group (except the control mice) were fused with mouse myeloma subclone X63Ag 8.6.5.3 at a ratio of 1:1. Fusion was performed by means of 50% (wt/vol) polyethylene glycol (PEG 1500; Boehringer Mannheim, Germany) according to standard procedures. As soon as hybridoma growth was macroscopically visible, supernatants were screened for antibody production by EIA with natural E. coli lipid A. Cloning of positive cultures was carried out by limiting dilution as described by Brandt et al. (9) . MAbs H348 and D7188 (see below and Table 3) were raised with HCI-treated S. minne- Table 3 . Polyclonal rabbit sera were described previously (6, 7) . MAbs S1 and S11-7 were derived from immunizations described above. MAbs A23, A24, and A43 were obtained from the same fusion as were Al and A6 (1). MAbs 1C3, 8A1, and 5E4 were kindly provided by R. Coughlin, Malvern, Pa., and H348 and D7188 were kindly provided by T. Ulrich, Hamilton, Mont.
Passive immunohemolysis (PIH) and hemolysis inhibition assay (19 
RESULTS
Characterization of MAbs reacting with a similar pattern by PIH and EIA. MAbs, raised in our laboratory and other laboratories with various immunogens, were screened for lipid A reactivity in the EIA and PIH test systems. Those MAbs which were characterized in this study are listed in Table 3 . In the EIA system, 12 of these MAbs were reactive with E. coli lipA-Ac, and 11 also reacted in the PIH system. The antibodies were further characterized by using differently phosphorylated and acylated synthetic lipid A antigens. Rabbit sera against synthetic E. coli lipid A and its monophosphoryl derivatives (6) were included as controls.
(i) Phosphate-dependent reactivity by PIH. In the PIH system, two sets of reactivity patterns were observed depending on the phosphate substitution of synthetic antigens. The first group reacted exclusively with bisphosphorylated compounds and not with their monophosphoryl derivatives (MAbs A6, Al, 1C3, 8A1, and 5E4 in Table 4 ). The other group reacted with bisphosphoryl compounds as well as with the 4'-monophosphoryl partial structures (MAbs A23, A24, Si, H348, and D7188 in Table 4 ). None of the MAbs reacted with 1-phosphoryl lipid A structures. The phosphate-dependent reaction patterns were observed with the three series of oligoacyl compounds (LA-19, LA-14, and LA-15), but with various titers (Table 4) . We have shown previously that antibodies to monosaccharide partial structures of lipid A cross-react with appropriate phosphorylated disaccharide compounds (6) . To find out whether the reactivity with 4'-monophosphoryl compounds was due to monosaccharidespecific antibodies, the respective MAbs were further characterized. Four of the five monophosphoryl lipid A-recognizing MAbs reacted with the 4-phosphoryl monosaccharide 89.575 (Table 5) . MAb Si was negative with compound 89.575, indicating that it required a disaccharide epitope. None of these MAbs reacted with 1-phosphorylated monosaccharide compounds (example shown in Table 5 ), thus underscoring the importance of the phosphate substitution pattern. As expected, none of the bisphosphoryl lipid A-specific MAbs reacted with either 1-or 4-phosphoryl monosaccharides (not shown).
(ii) Phosphate-dependent reactivity in inhibition of PIH. The grouping of MAbs into three distinct specificities was confirmed by PIH using synthetic compounds as inhibitors. As examples, data representative for MAbs with bisphosphoryl (A6), 4'-monophosphoryl (Si), and 4-phosphoryl monosaccharide (A24) lipid A specificity are shown in Table  6 . To inhibit MAb A6, significantly higher amounts of monophosphorylated compounds (up to 500 ng) than bisphosphoryl compounds (16 to 63 ng) were necessary. In the case of MAbs Si and A24, 4'-phosphoryl and bisphosphoryl compounds inhibited to a comparable extent, but much higher amounts of 1-phosphoryl antigens were needed to achieve the same degree of inhibition. As was noted Tables 1 and 2 and Fig. 1 well, however, A24 distinguished between the 1-monophosphoryl compound (titer, 10,000) and the 4'-monophosphoryl and bisphosphoryl compounds (titer, 320,000 each). Thus, it became obvious that by EIA, the preference of antibodies for a defined phosphate substitution pattern is seen only with very small amounts of antigen. We found that the amount of antigen allowing discrimination between compounds varies with the series of compounds as well as with the antibodies tested (27a). Therefore, for the discrimination of specificities, the titration of antigens with constant antibody dilution turned out to be superior to the titration of antibodies. With the titration of antigens, the reactivity patterns of antibodies were evident from the lowest antigen amounts detectable (Table 7) . Antibodies exclusively reactive with bisphosphoryl lipid A by PIH (e.g., A6) reacted with significantly lower amounts of these compounds by EIA compared with their monophosphoryl derivatives. MAbs positive with 4'-phosphoryl lipid A by PIH reacted with (iv) Influence of the acylation pattern of antigens on the reactivity of MAbs. In both the PIH and EIA systems, the phosphate-dependent reactivity patterns of MAbs were observed to be independent of the acyl content of the antigen. However, the absolute values obtained varied with the number of fatty acids in the respective compounds. To find out whether the epitopes perhaps comprised fatty acids, antibodies were tested with synthetic compounds possessing a structurally identical hydrophilic backbone but differing in their acylation patterns. Regardless of the acylation pattern, the MAbs reacted with all bisphosphorylated compounds (data from PIH in Table 8 and from EIA in Table 9 ). The same held true for the series of 4'-phosphoryl compounds when they were tested with the respective MAbs (data not shown). Exceptions are MAbs Si and H348, which reacted in the PIH system with all 4'-phosphoryl compounds except LA-15-PH. In the EIA system, however, they did react with compound LA-15-PH. Interestingly, all antibodies also reacted in the EIA system with compounds LA-16-PP and LA-22-PP (synthetic analogs of S. minnesota heptaacyl lipid A and C. violaceum lipid A, respectively). These compounds were not reactive by PIH, probably because of their inability to coat erythrocytes (17) . The good reactivity of MAbs with synthetic compounds, regardless of their acylation patterns, indicated that fatty acids are not part of the epitopes recognized. The degree of reactivity, however, was influenced by the number of acyl chains. We have shown previously (6) that the amount of antigen needed for optimal sensitization of SRBCs rises dramatically with an increasing number of acyl chains. When optimal antigen amounts for coating were used, rabbit antisera showed comparable titers in the PIH system with compounds of different acylation patterns (except K81 with compound LA-19-PP; Table 8 and reference  6) . Unlike what was observed with polyclonal sera, with all MAbs, compounds with four or five fatty acids yielded significantly higher titers in the PIH system than did preparations with two or six acyl chains. In the EIA system, similar amounts of antigens were detected, except for compounds with two acyl chains. The latter seemed less effective in coating plates, since the inhibition value of LA-19-PP (Table 6) proved to indicate good reactivity with the antibodies. The grouping of MAbs into three distinct specificities based on PIH data was confirmed by the results with EIA. However, unlike the clear results with the PIH, the specificity of antibodies with the EIA system was revealed only if minimal amounts of antigens were used. By both assays, the MAbs were characterized to represent three of the five specificities found in rabbit sera (6) . Within the group of solely bisphosphoryl lipid A-recognizing MAbs, no differ- Table 1 and Fig. 1 . Number of acyl chains is given in parentheses.
INFECT. IMMUN. Characterization of antibody specificities not described so far. (i) MAb S11-7, reactive with ETA but not with PIH. Only MAbs raised with 1-monophosphoryl compound LA-15-HP reacted with 1-phosphoryl compounds (38 other lipid A MAbs did not); however, they were inactive in the PIH assay, although all were of the IgM isotype. MAb S11-7 was further characterized; it reacted in the EIA system with 1-monophosphoryl lipid A (e.g., 2 ng of LA-15-HP per well was detected, compared with 25 ng of LA-15-PH) and with all bisphosphoryl compounds of different acylation patterns (data not shown). Reactivity with 1-phosphoryl monosaccharide compounds revealed that the epitope resided in the reducing monosaccharide region of lipid A. Since MAb S11-7 was inactive by PIH, control experiments were performed to exclude nonspecific "stickiness" causing the reactivity of the IgM MAb by EIA. Reactivity of S11-7 with E. coli lipA-Ac by EIA was inhibited by 1-monophosphoryl and bisphosphoryl lipid A (63 ng each). Binding to SRBCassociated antigen was shown by passive hemagglutination (titer of 32 against LA-15-PP and LA-15-HP and titer of 16 against monosaccharide-i-phosphate compound 880.319) and by the ability of SRBCs coated with lipA-Ac to absorb the antibody (titer < 10 with EIA). In all tests, the 4'-monophosphoryl compounds were negative.
(ii) Antibodies requiring no phosphate. The water-insoluble phosphate-free compounds (LA-14-HH and LA-15-HH) could be tested by EIA only as solid-phase antigens or as liposome membrane-embedded inhibitors. None of the antibodies described so far reacted with phosphate-free compounds by EIA (the inhibition values of LA-15-HH were 125 and 250 ng for K81 iand K64, respectively, and >500 ng for all other antibodies); however, MAb A43 reacted as well with phosphate-free as with phosphorylated compounds. Checkerboard titrations yielded identical titers (3, 200 ,000) with 20 ng of either phosphate-free or bisphosphorylated lipid A and even with 1 ng of antigen per well; titers differed only by one dilution step (200,000 against LA-15-HH and 400,000 against LA-15-PP). Liposome-embedded compounds LA-14-HH and LA-15-HH also inhibited the hemolytic system of MAb A43 and E. coli lipA-Ac with 8 and 2 ng, respectively. Except for A43, only homologous anti-LA-15-HH serum (K77) reacted with phosphate-free compounds by EIA. Unlike A43, serum K77 did not react at all with phosphorylated lipid A by PIH (7) (6) .
Variations in the hydrophilic backbone are recognized by MAbs as follows (Table 11 and Fig. 3 ). (i) One set of MAbs, A6 (shown in Fig. 3) and Al, 1C3, 8A1, and 5E4 (not shown), recognize the bisphosphorylated backbone (specificity a in (Table 11 ). Both monophosphorylated monosaccharide-and disaccharidespecific antibodies also detected their epitopes in bisphosphorylated disaccharides, whereas antibodies against bisphosphorylated disaccharide (lipid A) did not react with lipid A partial structures. This nonreciprocal cross-reaction with more complex structures had already been revealed with polyclonal rabbit sera (5, 6) . The only exception to this general rule was MAb A43, which did not react with 1-phosphorylated compounds.
Because of the cross-reaction of monosaccharide-specific antibodies with disaccharides, monophosphoryl monosaccharide-specific antibodies in rabbit sera could only be detected indirectly: their presence was previously proven by testing for retained disaccharide reactivity after the absorption of sera with monosaccharides. In addition, because of the described cross-reactivity, monosaccharide-specific antibodies could not be obtained separately by absorption of sera with disaccharides. As the present study shows, distinct monosaccharide-specific antibodies are now available. It was an interesting finding that immunization with whole bacteria resulted in, among other MAbs, those (A23, A24, and A43) recognizing monosaccharide lipid A partial structures. Previously, monosaccharide specificities were found only in sera raised with liposome membrane-embedded antigens (6) . These data on MAbs confirmed our conclusion from previous work that there exist several lipid A antibody specificities recognizing a distinct phosphorylation of the lipid A backbone (5-7); they differ, however, from our antibodies. Specificities c, dl, and g were found only in rabbit sera, and d2 and f were found only as murine MAbs. See also Table 11. previous data obtained with rabbit sera in three ways. (i) Among the 12 MAbs characterized here and 27 others (data not shown), no antibody was found to be specific for the 1-phosphorylated disaccharide, i.e., specificity c in Fig. 3 , present in polyclonal antiserum K81. (ii) In rabbit sera, significant reactivity with phosphate-free lipid A (specificity g in Fig. 3 ) was found only in the homologous serum K77 raised with phosphate-free LA-15-HH. However, MAb A43, which also reacted with phosphate-free lipid A, was obtained by immunization with Re bacteria. MAb A43 differed from rabbit serum K77 by its good reactivity with 4'-monophosphorylated and 1,4'-bisphosphoryl compounds. (iii) 4-Phosphate monosaccharide-specific MAbs and polyclonal antibodies bind to different epitopes (cf. specificities d1 and d2 in Fig. 3 ). Whereas rabbit sera (e.g., K64) did not distinguish in the PIH system between 4-phosphate monosaccharides with a fixed 3-anomeric configuration and those having a free reducing end (of which more than 90% are present as the ao-anomer), MAbs reacted only with the 3-configurated compound 89.575. The other ,B-methyl glycoside (compound 89.589) could not be tested by PIH, since it did not coat SRBCs because of the presence of two additional fatty acids. However, by EIA (data not shown), compounds 89.575 and 89.589 yielded similar results with MAbs A23, A24, H348, and D7188, indicating that in fact the negative reaction by PIH resulted from inefficient coating. This also shows that in addition to compounds LA-11-PH and 880.475, 3-methyl glycosides such as compounds 89.575 and 89.589 are useful test antigens for detecting the whole spectrum of 4-phosphoryl monosaccharide-specific lipid A antibodies.
The data obtained with monosaccharide antigens also demonstrated that neither MAbs nor rabbit sera distinguished between D-glucosamine (present in all disaccharide compounds) and 2,3-diamino-2,3-dideoxy-D-glucose as the backbone sugar. These two hexosamines are found as the backbone sugar of natural lipid A (33, 39) . Because of the conserved structure of lipid A, antibodies to this LPS component, either naturally occurring in human sera (32, 43) or induced by active immunization, were expected to crossreact and possibly cross-protect against a broad spectrum of LPS derived from gram-negative bacteria. (1) , whereas MAb 8A1 protected mice, although at a substantially lower level than with LPS typespecific antibody (13) .
As we have reported previously (6) , the immunoreactive properties of lipid A depend on its physicochemical environment. Differences in antibody reactivity observed here with various test systems suggested that epitopes were differently exposed and therefore strongly support this conclusion.
